Osaka, Japan

Hideyuki Yoshiyama

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Hideyuki Yoshiyama

Introduction

Hideyuki Yoshiyama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative methods for producing specific compounds. With a total of 7 patents to his name, Yoshiyama's work has had a notable impact on the industry.

Latest Patents

Yoshiyama's latest patents include methods of producing anamorelin hydrochloride with controlled chloride content. This invention relates to particulate forms of anamorelin monohydrochloride or compositions comprising this compound, which are preferably isolated in an amorphous and/or fine particulate state. The processes for making these particulate forms and the pharmaceutical compositions that include them are crucial advancements in the field.

Career Highlights

Throughout his career, Yoshiyama has worked with notable companies such as Helsinn Healthcare and Ono Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant pharmaceutical innovations.

Collaborations

Yoshiyama has collaborated with esteemed colleagues, including Shin-itsu Kuwabe and Takehiko Yanagimachi. These partnerships have fostered a collaborative environment that has led to the successful development of various pharmaceutical products.

Conclusion

Hideyuki Yoshiyama's contributions to pharmaceutical innovations through his patents and collaborations highlight his importance in the field. His work continues to influence the development of new and effective pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…